Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: ANTIRHEUMATIC AGENTS - ADVERSE EFFECTS , . Treffer: 20

2022

Kastrati, K; Aletaha, D; Burmester, GR; Chwala, E; Dejaco, C; Dougados, M; McInnes, IB; Ravelli, A; Sattar, N; Stamm, TA; Takeuchi, T; Trauner, M; van der Heijde, D; Voshaar, MJH; Winthrop, K; Smolen, JS; Kerschbaumer, A A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases
RMD OPEN. 2022; 8(2): e002359 Doi: 10.1136/rmdopen-2022-002359 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2019

Skrabl-Baumgartner, A; Seidel, G; Langner-Wegscheider, B; Schlagenhauf, A; Jahnel, J Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated uveitis.
Arch Dis Child. 2019; 104(3):246-250 Doi: 10.1136/archdischild-2018-315060
Web of Science PubMed FullText FullText_MUG

 

2017

Palmowski, Y; Buttgereit, T; Dejaco, C; Bijlsma, JW; Matteson, EL; Voshaar, M; Boers, M; Buttgereit, F "Official View" on Glucocorticoids in Rheumatoid Arthritis: A Systematic Review of International Guidelines and Consensus Statements.
Arthritis Care Res (Hoboken). 2017; 69(8):1134-1141 Doi: 10.1002/acr.23185 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Dejaco, C; Singh, YP; Perel, P; Hutchings, A; Camellino, D; Mackie, S; Abril, A; Bachta, A; Balint, P; Barraclough, K; Bianconi, L; Buttgereit, F; Carsons, S; Ching, D; Cid, M; Cimmino, M; Diamantopoulos, A; Docken, W; Duftner, C; Fashanu, B; Gilbert, K; Hildreth, P; Hollywood, J; Jayne, D; Lima, M; Maharaj, A; Mallen, C; Martinez-Taboada, V; Maz, M; Merry, S; Miller, J; Mori, S; Neill, L; Nordborg, E; Nott, J; Padbury, H; Pease, C; Salvarani, C; Schirmer, M; Schmidt, W; Spiera, R; Tronnier, D; Wagner, A; Whitlock, M; Matteson, EL; Dasgupta, B; European League Against Rheumatism; American College of Rheumatology 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
Arthritis Rheumatol. 2015; 67(10):2569-2580 Doi: 10.1002/art.39333 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Smolen, JS; Schoels, MM; Nishimoto, N; Breedveld, FC; Burmester, GR; Dougados, M; Emery, P; Ferraccioli, G; Gabay, C; Gibofsky, A; Gomez-Reino, JJ; Jones, G; Kvien, TK; Murakami, M; Betteridge, N; Bingham, CO; Bykerk, V; Choy, EH; Combe, B; Cutolo, M; Graninger, W; Lanas, A; Martin-Mola, E; Montecucco, C; Ostergaard, M; Pavelka, K; Rubbert-Roth, A; Sattar, N; Scholte-Voshaar, M; Tanaka, Y; Trauner, M; Valentini, G; Winthrop, KL; de Wit, M; van der Heijde, D Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions.
Ann Rheum Dis. 2013; 72(4):482-492 Doi: 10.1136/annrheumdis-2012-202469 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Brunasso, AMG; Massone, C Plantar pustulosis during rituximab therapy for rheumatoid arthritis
J Am Acad Dermatol. 2012; 67(4):e148-e150 Doi: 10.1016/j.jaad.2011.12.010 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Bykerk, VP; Ostör, AJ; Alvaro-Gracia, J; Pavelka, K; Ivorra, JA; Graninger, W; Bensen, W; Nurmohamed, MT; Krause, A; Bernasconi, C; Stancati, A; Sibilia, J Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice.
Ann Rheum Dis. 2012; 71(12):1950-1954 Doi: 10.1136/annrheumdis-2011-201087 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2011

Broy, SB; Tanner, SB; FRAX(®)Position Development Conference Members Official Positions for FRAX® clinical regarding rheumatoid arthritis from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
J Clin Densitom. 2011; 14(3):184-189 Doi: 10.1016/j.jocd.2011.05.012
Web of Science PubMed FullText FullText_MUG

 

2010

Brunasso, AM; Laimer, M; Massone, C Paradoxical reactions to targeted biological treatments: A way to treat and trigger?
Acta Derm Venereol. 2010; 90(2):183-185 Doi: 10.2340/00015555-0777 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Brunasso, AM; Scocco, GL; Massone, C Dermatomyositis during adalimumab therapy for rheumatoid arthritis.
J Rheumatol. 2010; 37(7):1549-1550 Doi: 10.3899/jrheum.091413 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2009

Aringer, M; Houssiau, F; Gordon, C; Graninger, WB; Voll, RE; Rath, E; Steiner, G; Smolen, JS Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
Rheumatology (Oxford). 2009; 48(11):1451-1454 Doi: 10.1093/rheumatology/kep270 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Dejaco, C; Duftner, C; Wipfler, E; Schirmer, M A novel treatment option in rheumatoid arthritis: abatacept, a selective modulator of T-cell co-stimulation
Wien Med Wochenschr. 2009; 159(3-4): 70-75. Doi: 10.1007/s10354-008-0590-3
PubMed FullText FullText_MUG

 

2008

Brezinschek, HP; Hofstaetter, T; Leeb, BF; Haindl, P; Graninger, WB Immunization of patients with rheumatoid arthritis with antitumor necrosis factor alpha therapy and methotrexate.
Curr Opin Rheumatol. 2008; 20(3):295-299 Doi: 10.1097/BOR.0b013e3282ffdeca
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Hermann, J; Kovacs, G; Scheidl, S Interdisciplinary point of contact between rheumatology and pneumology
Z RHEUMATOL. 2008; 67(5): 412- 414. Doi: 10.1007/s00393-008-0346-x
Web of Science PubMed FullText FullText_MUG

 

2007

Thonhofer, R; Uitz, E; Graninger, W Schnitzler's syndrome--exacerbation after anti-TNF treatment.
RHEUMATOLOGY. 2007; 46(6): 1041-1042. Doi: 10.1093/rheumatology/kem048 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2006

Braun, J; Zochling, J; Baraliakos, X; Alten, R; Burmester, G; Grasedyck, K; Brandt, J; Haibel, H; Hammer, M; Krause, A; Mielke, F; Tony, HP; Ebner, W; Gömör, B; Hermann, J; Zeidler, H; Beck, E; Baumgaertner, M; Sieper, J Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial.
ANN RHEUM DIS. 2006; 65(9): 1147-1153. Doi: 10.1136/ard.2006.052878 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2005

Kneitz, C; Suerbaum, S; Beer, M; Muller, J; Jahns, R; Tony, HP Exacerbation of Whipple's disease associated with infliximab treatment
Scand J Rheumatol. 2005; 34(2):148-151 Doi: 10.1080/03009740510015230 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Vallbracht, II; Popper, HH; Rieber, J; Nowak, F; Gallenberger, S; Piper, B; Helmke, K Lethal pneumonitis under leflunomide therapy.
RHEUMATOLOGY. 2005; 44(12): 1580-1581. Doi: 10.1093/rheumatology/kei076 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2004

Bubbear, JS; Keen, RW New guidelines for corticosteroid-induced osteoporosis.
RHEUMATOLOGY. 2004; 43(5): 676-677. Doi: 10.1093/rheumatology/keh095 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2001

Woltsche, M; Woltsche-Kahr, I; Roeger, GM; Aberer, W; Popper, H Sulfasalazine-induced extrinsic allergic alveolitis in a patient with psoriatic arthritis.
Eur J Med Res. 2001; 6(11):495-497 (- Case Report)
Web of Science PubMed Google Scholar

 

© Med Uni Graz Impressum